List of articles with "South San Francisco"

ESSA's Acquisition Deal

ESSA's Acquisition Deal

USA ESSA Pharma South San Francisco XenoTherapeutics XOMA Royalty
Centivax Funding Success

Centivax Funding Success

United States South San Francisco Vaccine Development Centivax Universal Immunity
Rigel Grants Announced

Rigel Grants Announced

USA NASDAQ South San Francisco Rigel Pharmaceuticals Inducement Grants
IDEAYA Expands Talent

IDEAYA Expands Talent

United States IDEAYA Biosciences South San Francisco Precision Medicine Nasdaq Listing
HLI's $1M Pancreatic Cancer Pledge

HLI's $1M Pancreatic Cancer Pledge

United States Inc. pancreatic cancer South San Francisco Precision Medicine Human Longevity
Deep Apple and Novo Nordisk Collaboration

Deep Apple and Novo Nordisk Collaboration

USA South San Francisco Novo Nordisk Therapeutics Deep Apple
Deep Apple and Novo Nordisk

Deep Apple and Novo Nordisk

USA South San Francisco Novo Nordisk Deep Apple cardiometabolic
Deep Apple & Novo Nordisk

Deep Apple & Novo Nordisk

USA South San Francisco Novo Nordisk Deep Apple cardiometabolic
Deep Apple & Novo Nordisk

Deep Apple & Novo Nordisk

USA South San Francisco Novo Nordisk Deep Apple cardiometabolic
Deep Apple and Novo Nordisk

Deep Apple and Novo Nordisk

USA South San Francisco Novo Nordisk Deep Apple cardiometabolic
IDEAYA Grants Stock Options

IDEAYA Grants Stock Options

United States NASDAQ stock options IDEAYA Biosciences South San Francisco
Rigel's Presentations at Conferences

Rigel's Presentations at Conferences

United States South San Francisco Rigel Pharmaceuticals REZLIDHIA GAVRETO
ESSA Pharma Q2 Results

ESSA Pharma Q2 Results

USA ESSA Pharma South San Francisco Prostate Cancer NASDAQ EPIX
Rigel's Q1 Performance

Rigel's Q1 Performance

USA South San Francisco Rigel Pharmaceuticals R289 TAVALISSE
Advancing Cancer Prevention

Advancing Cancer Prevention

USA pancreatic cancer South San Francisco Human Longevity Avantect
IDEAYA 2025 Financial Update

IDEAYA 2025 Financial Update

USA Clinical Trials IDEAYA Biosciences South San Francisco darovasertib
FDA Clearance for IDE849

FDA Clearance for IDE849

USA IDEAYA Biosciences South San Francisco IDE849 DLL3
Atlas Data Storage Financing

Atlas Data Storage Financing

United States South San Francisco Atlas Data Storage DNA Technology Seed Financing
IDEAYA Grants Stock Options

IDEAYA Grants Stock Options

United States stock options IDEAYA Biosciences Nasdaq rule South San Francisco
FDA Guidance on Darovasertib

FDA Guidance on Darovasertib

United States IDEAYA Biosciences South San Francisco uveal melanoma darovasertib
Rivus Expands Team

Rivus Expands Team

United States South San Francisco Rivus Pharmaceuticals HU6 cardiometabolic diseases
IDEAYA Expands Cancer Study

IDEAYA Expands Cancer Study

United States IDEAYA Biosciences South San Francisco Trodelvy IDE397
Rigel Inducement Grants

Rigel Inducement Grants

United States stock options South San Francisco Rigel Pharmaceuticals Inducement Grants
Darovasertib's FDA Approval

Darovasertib's FDA Approval

United States IDEAYA Biosciences South San Francisco uveal melanoma darovasertib
IDEAYA Grants Stock Options

IDEAYA Grants Stock Options

USA NASDAQ stock options IDEAYA Biosciences South San Francisco
Rigel Settles TAVALISSE Patent Case

Rigel Settles TAVALISSE Patent Case

United States South San Francisco Rigel Pharmaceuticals TAVALISSE Annora Pharma
Human Longevity's Cancer Initiative

Human Longevity's Cancer Initiative

United States South San Francisco Precision Medicine Prostate Cancer Human Longevity
Vaccine Collaboration

Vaccine Collaboration

USA South San Francisco Universal Vaccine Centivax Emery Pharma
Dr. Frohlich Joins Rigel

Dr. Frohlich Joins Rigel

USA oncology South San Francisco Rigel Pharmaceuticals Mark Frohlich
ESSA Pharma Meeting

ESSA Pharma Meeting

USA ESSA Pharma South San Francisco Prostate Cancer David Parkinson
Rigel's 2024 Financial Success

Rigel's 2024 Financial Success

USA South San Francisco Rigel Pharmaceuticals TAVALISSE REZLIDHIA
Leadership Changes at 3T

Leadership Changes at 3T

United States South San Francisco 3T Biosciences Marvin Gee Barbara Sennino
Breakthrough Drug Discovery

Breakthrough Drug Discovery

United States oncology South San Francisco IDEAYA ATTMOS
IDEAYA Inducement Grants

IDEAYA Inducement Grants

United States NASDAQ stock options IDEAYA Biosciences South San Francisco
Mytra Hires Tesla's CFO

Mytra Hires Tesla's CFO

USA Tesla South San Francisco Mytra Gabi Gantus
Perceive Pharma Funding

Perceive Pharma Funding

USA South San Francisco ophthalmology glaucoma Perceive Pharma
New Study on NSCLC

New Study on NSCLC

United States South San Francisco IDEAYA Gilead Trodelvy
IDEAYA Biosciences Update

IDEAYA Biosciences Update

USA oncology IDEAYA Biosciences South San Francisco darovasertib
ESSA Pharma's Q1 Update

ESSA Pharma's Q1 Update

United States ESSA Pharma South San Francisco Prostate Cancer masofaniten
Joshua Bleharski Joins IDEAYA

Joshua Bleharski Joins IDEAYA

United States biotechnology IDEAYA Biosciences South San Francisco Joshua Bleharski
IDEAYA Grants Stock Options

IDEAYA Grants Stock Options

United States NASDAQ stock options IDEAYA Biosciences South San Francisco
Tahoe-100M Open Source

Tahoe-100M Open Source

United States South San Francisco NVIDIA Vevo Therapeutics Tahoe-100M
Revolutionizing Sleep Health

Revolutionizing Sleep Health

United States Sleep Health South San Francisco Human Longevity SleepScore Labs
Rigel Pharmaceuticals Update

Rigel Pharmaceuticals Update

USA South San Francisco Rigel Pharmaceuticals TAVALISSE REZLIDHIA
IDEAYA at J.P. Morgan

IDEAYA at J.P. Morgan

USA J.P. Morgan IDEAYA Biosciences South San Francisco Precision Medicine
Rigel's R289 Receives FDA Designation

Rigel's R289 Receives FDA Designation

United States South San Francisco Rigel Pharmaceuticals R289 MDS
Rigel Grants Stock Options

Rigel Grants Stock Options

United States stock options South San Francisco Rigel Pharmaceuticals RIGL
IDEAYA and Hengrui Collaboration

IDEAYA and Hengrui Collaboration

United States South San Francisco IDEAYA Hengrui Pharma SHR-4849
Strategic Stock Options Grant

Strategic Stock Options Grant

United States stock options IDEAYA Biosciences South San Francisco Precision Medicine
ESSA Pharma Update

ESSA Pharma Update

United States ESSA Pharma South San Francisco Prostate Cancer masofaniten

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.